MARKET INTRODUCTION
Androgen deprivation therapy (ADT), also known as androgen suppression therapy, is carried out in men having prostate cancer. The pancreas is an androgen-dependent organ, and by providing ADT, it is possible to provide treatment for advanced and metastatic disease. Also, ADT is used along with external beam radiotherapy (EBRT) for intermediate to high-risk prostate cancer cases to improve responses to radiation. It is estimated that around 40% of patients diagnosed with prostate cancer would receive ADT within six months of diagnosis.
MARKET DYNAMICS
The androgen deprivation therapy market is anticipated to grow in the forecast, owing to the rise in the number of deaths caused due to prostate cancer, coupled with the rising demand for better medication. Also, the increase in R&D activities for the introduction of novel treatments for cancer is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Androgen Deprivation Therapy Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the androgen deprivation therapy market with detailed market segmentation by drug class, mode of administration, distribution channel, and geography. The androgen deprivation therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading androgen deprivation therapy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The androgen deprivation therapy market is segmented based on drug class, mode of administration, and distribution channel. Based on drug class, the market is segmented as antiandrogens, luteinizing hormone-releasing hormone (LHRH) agonists, LHRH antagonists, and other drug classes. Based on the mode of administration, the market is categorized as injectable and oral. Based on the distribution channel, the market is segmented as hospital pharmacies, online pharmacies, and retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the androgen deprivation therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The androgen deprivation therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting androgen deprivation therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the androgen deprivation therapy market in these regions.

MARKET PLAYERS
The report covers key developments in the androgen deprivation therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from androgen deprivation therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for androgen deprivation therapy market in the global market. Below mentioned is the list of few companies engaged in the androgen deprivation therapy market.
The report also includes the profiles of key androgen deprivation therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Allergan, Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca
- Bayer AG
- Johnson & Johnson Services, Inc.
- Orion Corporation
- Pfizer Inc.
- Sanofi
- Veru Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.